Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Daniel Willis
UK start-up Entocycle is looking to revolutionize the animal feed market through a sustainable, automated insect protein production system. Animal Pharm analyst Daniel Willis spoke to James Millar, the firm's chief commercial officer, to learn more about its strategy.
Swiss firm Embion Technologies is looking to source series B funding of $3 million to develop its prebiotics.
US biotechnology firm Mazen Animal Health is ready to scale up its R&D for low-cost oral recombinant vaccines.
Brazilian company NGS Genomics Solutions is looking for funding to develop its next-generation sequencing technology.
AB Vista has appointed Cathy Bandyk to the role of ruminant technical manager for North America, Mexico and Brazil.
Austrian animal nutrition company Biomin has launched FUMzyme sol, which it claims is the first water-soluble purified enzyme that degrades fumonisins into non-toxic metabolites.